{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:49:50Z","timestamp":1761518990487},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s11596-010-0350-7","type":"journal-article","created":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T13:58:47Z","timestamp":1277215127000},"page":"322-325","source":"Crossref","is-referenced-by-count":6,"title":["Expression of FANCD2 in sporadic breast cancer and clinicopathological analysis"],"prefix":"10.1007","volume":"30","author":[{"given":"Bo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinfang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,17]]},"reference":[{"issue":"5645","key":"350_CR1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"M.C. King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science, 2003,302(5645):643\u2013646","journal-title":"Science"},{"issue":"1","key":"350_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-009-0566-z","volume":"119","author":"L. Bordeleau","year":"2010","unstructured":"Bordeleau L, Panchal S, Goodwin P. Prognosis of BRCA-associated breast cancer: a summary of evidence. Breast Cancer Res Treat, 2010,119(1):13\u201324","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl","key":"350_CR3","first-page":"S16","volume":"124","author":"A.M. Oliveira","year":"2005","unstructured":"Oliveira AM, Ross JS, Fletcher JA. Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. Am J Clin Pathol, 2005,124(Suppl):S16\u201328","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"350_CR4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12282-009-0124-x","volume":"16","author":"H. Tsuda","year":"2009","unstructured":"Tsuda H. Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression. Breast Cancer, 2009,16(3):186\u2013201","journal-title":"Breast Cancer"},{"issue":"1","key":"350_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10549-007-9534-7","volume":"107","author":"P. Groep van der","year":"2008","unstructured":"van der Groep P, Hoelzel M, Buerger H, et al. Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer. Breast Cancer Res Treat, 2008,107(1): 41\u201347","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"350_CR6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/86832","volume":"27","author":"H. Youssoufian","year":"2001","unstructured":"Youssoufian H. Fanconi anemia and breast cancer: what\u2019s the connection? Nat Genet, 2001,27(4):352\u2013353","journal-title":"Nat Genet"},{"issue":"4","key":"350_CR7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/mp.56.4.198","volume":"56","author":"J. Packeisen","year":"2003","unstructured":"Packeisen J, Korsching E, Herbst H, et al. Demystified Tissue microarray technology. Mol Pathol, 2003,56(4): 198\u2013204","journal-title":"Mol Pathol"},{"issue":"34","key":"350_CR8","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2008.17.3567","volume":"26","author":"R.L. Camp","year":"2008","unstructured":"Camp RL, Neumeister V, Rimm DL. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol, 2008,26(34): 5630\u20135637","journal-title":"J Clin Oncol"},{"issue":"2","key":"350_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semradonc.2007.10.006","volume":"18","author":"D. Voduc","year":"2008","unstructured":"Voduc D, Kenney C, Nielsen TO. Tissue microarrays in clinical oncology. Semin Radiat Oncol, 2008,18(2): 89\u201397","journal-title":"Semin Radiat Oncol"},{"issue":"21","key":"350_CR10","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1158\/0008-5472.CAN-09-1067","volume":"69","author":"M.I. Vitolo","year":"2009","unstructured":"Vitolo MI, Weiss MB, Szmacinski M, et al. Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Cancer Res, 2009,69(21):8275\u20138283","journal-title":"Cancer Res"},{"issue":"12","key":"350_CR11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ncb892","volume":"4","author":"R.A. DiTullio Jr","year":"2002","unstructured":"DiTullio RA Jr, Mochan TA, Venere M, et al. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat Cell Biol, 2002,4(12):998\u20131002","journal-title":"Nat Cell Biol"},{"issue":"7035","key":"350_CR12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"J. Bartkova","year":"2005","unstructured":"Bartkova J, Horejs\u00ed Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature, 2005,434(7035): 864\u2013870","journal-title":"Nature"},{"issue":"9","key":"350_CR13","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/carcin\/bgl062","volume":"27","author":"E. Barroso","year":"2006","unstructured":"Barroso E, Milne RL, Fern\u00e1ndez LP, et al. FANCD2 associated with sporadic breast cancer risk. Carcinogenesis, 2006,27(9):1930\u20131937","journal-title":"Carcinogenesis"},{"issue":"3","key":"350_CR14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10549-009-0439-5","volume":"118","author":"E. Barroso","year":"2009","unstructured":"Barroso E, Pita G, Arias JI, et al. The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features. Breast Cancer Res Treat, 2009,118(3):655\u2013660","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"350_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc970","volume":"3","author":"A.D. D\u2019Andrea","year":"2003","unstructured":"D\u2019Andrea AD, Grompe M. The Fanconi anemia\/BRCA pathway. Nat Rev Cancer, 2003,3(1):23\u201334","journal-title":"Nat Rev Cancer"},{"issue":"15","key":"350_CR16","doi-asserted-by":"crossref","first-page":"14 877","DOI":"10.1074\/jbc.M414669200","volume":"280","author":"A. Ohashi","year":"2005","unstructured":"Ohashi A, Zdzienicka MZ, Chen J, et al. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage. J Biol Chem, 2005,280(15):14 877\u201314 883","journal-title":"J Biol Chem"},{"issue":"5","key":"350_CR17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.molcel.2009.06.034","volume":"35","author":"X. Shen","year":"2009","unstructured":"Shen X, Do H, Li Y, et al. Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication. Mol Cell, 2009,35(5): 716\u2013723","journal-title":"Mol Cell"},{"issue":"16","key":"350_CR18","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1101\/gad.1103403","volume":"17","author":"S. Houghtaling","year":"2003","unstructured":"Houghtaling S, Timmers C, Noll M, et al. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev, 2003,17(16): 2021\u20132035","journal-title":"Genes Dev"},{"issue":"1\u20132","key":"350_CR19","first-page":"3","volume":"28","author":"M. Levitus","year":"2006","unstructured":"Levitus M, Joenje H, de Winter JP. The Fanconi anemia pathway of genomic maintenance. Cell Oncol, 2006, 28(1\u20132):3\u201329","journal-title":"Cell Oncol"},{"issue":"8","key":"350_CR20","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/sj.emboj.7601666","volume":"26","author":"C. Ling","year":"2007","unstructured":"Ling C, Ishiai M, Ali AM, et al. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J, 2007,26(8): 2104\u20132114","journal-title":"EMBO J"},{"issue":"42","key":"350_CR21","doi-asserted-by":"crossref","first-page":"28 935","DOI":"10.1074\/jbc.M109.016352","volume":"284","author":"N.G. Howlett","year":"2009","unstructured":"Howlett NG, Harney JA, Rego MA, et al. Functional interaction between the Fanconi anemia D2 protein and proliferating cell nuclear antigen (PCNA) via a conserved putative PCNA interaction motif. J Biol Chem, 2009,284(42):28 935\u201328 942","journal-title":"J Biol Chem"},{"issue":"2","key":"350_CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1097-2765(01)00173-3","volume":"7","author":"I. Garcia-Higuera","year":"2001","unstructured":"Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell, 2001,7(2):249\u2013262","journal-title":"Mol Cell"},{"issue":"13","key":"350_CR23","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1128\/MCB.24.13.5850-5862.2004","volume":"24","author":"X. Wang","year":"2004","unstructured":"Wang X, Andreassen PR, D\u2019Andrea AD. Functional interaction of monoubiquitinated FANCD2 and BRCA2\/FANCD1 in chromatin. Mol Cell Biol, 2004,24(13):5850\u20135862","journal-title":"Mol Cell Biol"},{"issue":"10","key":"350_CR24","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","volume":"4","author":"N. Turner","year":"2004","unstructured":"Turner N, Tutt A, Ashworth A. Hallmarks of\u2019 BRCAness\u2019 in sporadic cancers. Nat Rev Cancer, 2004, 4(10):814\u2013819","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"350_CR25","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/1535-7163.MCT-05-0493","volume":"5","author":"D. Chirnomas","year":"2005","unstructured":"Chirnomas D, Taniguchi T, de la Vega M, et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia\/BRCA pathway. Mol Cancer Ther, 2005,5(4): 952\u2013961","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"350_CR26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2007.06.006","volume":"256","author":"A. Lyakhovich","year":"2007","unstructured":"Lyakhovich A, Surralles J. FANCD2 depletion sensitizes cancer cells repopulation ability in vitro. Cancer Lett, 2007,256(2):186\u2013195","journal-title":"Cancer Lett"},{"issue":"4","key":"350_CR27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2174\/187152008784220267","volume":"8","author":"S.N. Powell","year":"2008","unstructured":"Powell SN, Kachnic LA. Therapeutic exploitation of tumor cell defects in homologous recombination. Anticancer Agents Med Chem, 2008,8(4):448\u2013460","journal-title":"Anticancer Agents Med Chem"},{"issue":"8","key":"350_CR28","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/1541-7786.MCR-09-0149","volume":"7","author":"H. Willers","year":"2009","unstructured":"Willers H, Taghian AG, Luo CM, et al. Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies. Mol Cancer Res, 2009,7(8):1304\u20131309","journal-title":"Mol Cancer Res"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-010-0350-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-010-0350-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-010-0350-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:15:05Z","timestamp":1559394905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-010-0350-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["350"],"URL":"https:\/\/doi.org\/10.1007\/s11596-010-0350-7","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}